Black Rock Inc. Scopus Bio Pharma Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.36 - $0.74 $13,203 - $27,139	-36,675 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.6 - $1.7 $10,288 - $29,149	17,147 Added 87.81%	36,675 $25,000
Q4 2021 Feb 10, 2022	BUY	$1.63 - $4.28 $831 - $2,182	510 Added 2.68%	19,528 $32,000
Q3 2021 Nov 09, 2021	BUY	$4.0 - $6.99 $71,000 - $124,072	17,750 Added 1399.84%	19,018 $79,000
Q2 2021 Aug 11, 2021	BUY	$5.17 - $10.25 $6,555 - $12,997	1,268 New	1,268 $9,000

Ticker SCPS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,094,300
Description
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.